BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Contract Services Contract Manufacturing

Vetter Site status now ‘ready for media fill’

Vetter, a leading global Contract Development and Manufacturing Organization (CDMO) has further invested in additional capacity to meet this growin...

July 21, 2021 | News

Samsung Biologics and Kineta Announce CDMO Agreement

Kineta to leverage Samsung Biologics' development and manufacturing expertise to advance KVA12.1 to IND Samsung Biologics San Francisco R&D cent...

July 21, 2021 | News

Novotech expands virtual clinical trials capabilities

The round was led by two new partners: Dedalus Group a leading healthcare and diagnostic software provider in Europe backed by Ardian, and Novotech H...

July 19, 2021 | News

Lonza Extends Collaboration with Major Biopharmaceutical Partner

Long-term collaboration for commercial supply of monoclonal antibodies will complete the integrated supply chain for the manufacture of an antibody-drug ...

July 17, 2021 | News

Merck and Universal Agree on the large-scale production of a new pediatric medication.

Merck has entered into a contract manufacturing agreement with Universal Corporation Ltd., Nairobi, Kenya, for the large-scale production of a new pediatri...

July 16, 2021 | News

Bora Group announce the rebranding of Yuta Health to Bora Health

With the name change, Bora plans to complete the merging of the operations of Bora Health and Union Chemical & Pharmaceutical by the end of 2021. In th...

July 06, 2021 | News

Aragen Announces Expansion of Discovery Research Agreement with Boehringer Ingelheim

This preferred partnership allows Boehringer Ingelheim, a leading research driven pharmaceutical company, to incorporate several design elements, synthesiz...

June 30, 2021 | News

Samsung Biologics continues to leverage remote audits and regulatory inspections

Samsung Biologics' Live Virtual Tour (LVT) used in one of the earliest FDA full virtual assessments Recently hosted EMA for 6 PAIs simultaneously using ...

June 24, 2021 | News

Vibalogics to expand cGMP manufacturing capacity for viral vectors

The investment by the CDMO, which specializes in the production of oncolytic viruses, viral vector vaccines and viral vector gene therapy products includes...

June 17, 2021 | News

Medidata to Offer Secure Platform for Decentralization of Clinical Trials

The first company in the world to unify direct patient data capture technology with study oversight and monitoring, Medidata redefines end-to-end...

June 16, 2021 | News

WuXi XDC and LCB Signed MOU for the Development and Manufacturing of Antibody-drug Conjugates

Under the partnership, LCB will have access to XDC' integrated services in mAb, linker, payload, analytical and formulation development as well as ADC drug...

June 10, 2021 | News

iResearch Atlanta welcomes new investigators and expands its operations

iResearch Atlanta welcomes new investigators and expands its operations to serve more patients in phase I-IV clinical trials, the ability to cont...

June 10, 2021 | News

Samsung Biologics and KAHR Medical Announce Development and Manufacturing Agreement for Cancer Immunotherapy Drug Candidate

Samsung Biologics (KRX: 207940.KS), the world’s leading contract development and manufacturing organization, signed a strategic partnership with KAHR...

June 03, 2021 | News

Moderna, Thermo Agreement to leverage manufacturing capacity to continue to drive global supply of vaccines

Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that it has entered i...

June 02, 2021 | News

Stay Connected